Information  X 
Enter a valid email address

Sareum Holdings PLC ORD 0.025P (SAR)

Date Time Source Announcement
11 Jul 2018 9:38 am
RNS
Notification of PCA Shareholding
15 Jun 2018 7:00 am
RNS
Advisers
31 May 2018 7:00 am
RNS
Sareum regains rights to Aurora+FLT3 inhibitors
10 May 2018 12:21 pm
RNS
SRA737 trial update in Sierra Oncology Q1 Results
24 Apr 2018 7:00 am
RNS
Sareum to Present at BioTrinity 2018 in London
17 Apr 2018 12:45 pm
RNS
AACR 2018 Update
15 Mar 2018 7:00 am
RNS
Late-breaker abstract for SRA737 accepted for AACR
13 Mar 2018 7:00 am
RNS
Interim Results
27 Feb 2018 12:50 pm
RNS
Sierra Oncology expands SRA737 development program
22 Feb 2018 7:00 am
RNS
Preclinical synergy of sra737 and PARP inhibitor
13 Feb 2018 7:00 am
RNS
Notice of Interim Results
20 Dec 2017 11:00 am
RNS
Issue of Options
19 Dec 2017 7:00 am
RNS
Patent Grants in Japan & China for TYK2 Inhibitors
14 Dec 2017 11:01 am
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
20 Nov 2017 7:00 am
RNS
Notice of AGM and Annual Report & Accounts
14 Nov 2017 12:05 pm
RNS
Placing
31 Oct 2017 7:00 am
RNS
Sierra Reports Preclinical Data for Chk1 Inhibitor
19 Oct 2017 7:00 am
RNS
Final Results
09 Oct 2017 12:00 pm
RNS
Sierra Oncology host KOL Meeting on 12 Oct in NY
18 Sep 2017 12:00 pm
RNS
Sierra Oncology to host call on Chk1 inhibitor
22 Aug 2017 7:00 am
RNS
Pre-Close Trading Statement
19 Jun 2017 7:00 am
RNS
Sareum to Present at the ICCS 2017
05 Jun 2017 12:13 pm
RNS
Chk1 Clinical Trials Update
31 May 2017 7:00 am
RNS
Sierra Oncology Granted US and EU Patents
25 May 2017 7:00 am
RNS
Sierra Oncology to Present at ASCO Annual Meeting
09 May 2017 7:00 am
RNS
Sareum to Present at BioTrinity 2017
09 Mar 2017 7:00 am
RNS
Director Shareholding
20 Feb 2017 7:00 am
RNS
Half-year Results
09 Feb 2017 7:00 am
RNS
Notice of Interim Results
09 Jan 2017 12:05 pm
RNS
Milestone Payment from Chk1 Licence Agreement
22 Dec 2016 9:47 am
RNS
Result of General Meeting
15 Dec 2016 11:38 am
RNS
Result of AGM
06 Dec 2016 7:00 am
RNS
Directors' Remuneration & General Meeting
29 Nov 2016 7:00 am
RNS
Sareum to Present at AACR-NCI-EORTC Conference
21 Nov 2016 7:00 am
RNS
Notice of AGM
02 Nov 2016 7:00 am
RNS
Final Results
24 Oct 2016 7:00 am
RNS
Successful Outcome from TYK2 Feasibility Study
17 Oct 2016 7:00 am
RNS
Japan and Singapore Patent Grants
27 Sep 2016 12:02 pm
RNS
Licence agreement for Chk1 Inhibitor CCT245737
03 Aug 2016 7:00 am
RNS
China & HK Patent Grants for Sareum's Aurora+FLT3
28 Jul 2016 7:00 am
RNS
Movement in share price
23 May 2016 12:00 pm
RNS
Clinical Trials CHK1 Inhibitor CCT245737 to Open
17 May 2016 7:00 am
RNS
Change of Director
05 Apr 2016 10:38 am
RNS
CHK1 Approved for Clinical Trials
24 Mar 2016 11:54 am
RNS
Placing
14 Mar 2016 7:00 am
RNS
Issue of Options
10 Mar 2016 12:55 pm
RNS
Share price movement
24 Feb 2016 7:01 am
RNS
Research & Co-Development Collaborations Update
  7:00 am
RNS
Half-Yearly Results for December 2015
01 Feb 2016 7:00 am
RNS
CHK1 Clinical Trial Application Submissions
15 Dec 2015 11:20 am
RNS
Result of AGM
  7:00 am
RNS
CHK1 Clinical Trial Applications
13 Nov 2015 10:15 am
RNS
Notice of AGM
26 Oct 2015 7:00 am
RNS
Final Results
15 Sep 2015 7:00 am
RNS
US and European Patent Grants for Aurora+FLT3
23 Jul 2015 7:00 am
RNS
CHK1 Research Update
17 Jun 2015 7:00 am
RNS
Funding Award from Innovate UK
28 May 2015 7:00 am
RNS
Placing
21 May 2015 7:00 am
RNS
Sareum Launches New Website
 
Headlines
Top categories

19-Jul-2018 08:31 AM

Sports Direct profits slump 73% amid losses on investment in Debenhams

Discount retailer Sports Direct said Thursday reported profits plunged 73% weighed down by its large stake in struggling retailer Debenhams. For the ...

19-Jul-2018 07:00 AM

Economic Events - Today's Events

Company finder

a d v e r t i s e m e n t